Amirali Popat is a Director of Research at The University of Queensland’s School of Pharmacy. He also holds an adjunct appointment as a Senior Research Fellow at University of Vienna. He graduated with a PhD in Nanomedicine from Australian Institute of Bioengineering and Nanotechnology (AIBN), UQ in 2012. His research focuses on development of stimuli responsive nanomaterials to overcome multiple biological barriers for precision medicine, in particular development of smart oral drug delivery systems for the treatment of IBD, Diabetes and Cancer. He has won many prestigious awards including Higher Degree Research Supervision award, Controlled Release Society’s early career researcher award, Queensland Young Tall Poppy Science Award to name a few. He is an immediate past president of Australian Controlled Release Society (AusCRS) and an associate editor of Journal of Controlled Release and editorial board member of DDTR, ADDR, Biomaterials Science and many more.
Webpage
